FindTrial
Sign In

Micro-biological and clinical evaluation of the results after adjuvanter laser therapy with 810nm diode laser in frame the parodontologic basis therapy

Micro-biological and clinical evaluation of the results after adjuvanter laser therapy with 810nm diode laser in frame the parodontologic basis therapy

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2009-015888-14-AT
Enrollment
Unknown
Registered
2010-04-26
Start date
2010-05-06
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Paradontosis

Interventions

Trade Name: ICG-Pulsion - Pulver zur Herstellung einer Injektionsloesung Product Name: ISG-Pulsion Pharmaceutical Form: Powder for injection* CAS Number: 3599-32-4 Other descriptive name: INDOCYANINE

Sponsors

Fa.Elexxion
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - signed ICF - Paradantose-Diagnosis - negativ pregnance-test Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: -Diabetes mellitus -systematic illnesses, which need a hormone therapy -pregnance -Iodine allergy

Design outcomes

Primary

MeasureTime frame
Main Objective: proof of an improvement of the therapy success of the parodontologic- basis therapy by adjuvanten employment of a photo-dynamic therapy;Secondary Objective: ;Primary end point(s): proof of an improvement of the therapy success of the parodontologic- basis therapy by adjuvanten employment of a photo-dynamic therapy—

Countries

Austria

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026